Earnings Summary

Myriad Genetics Inc.’s revenue jumped 15.26% since last year same period to $211.5Mn in the Q2 2024. On a quarterly growth basis, Myriad Genetics Inc. has generated 4.6% jump in its revenue since last 3-months.

Myriad Genetics Inc.’s net profit jumped 68.39% since last year same period to $-36.7Mn in the Q2 2024. On a quarterly growth basis, Myriad Genetics Inc. has generated -41.15% fall in its net profits since last 3-months.

Myriad Genetics Inc.’s net profit margin jumped 72.57% since last year same period to -17.35% in the Q2 2024. On a quarterly growth basis, Myriad Genetics Inc. has generated -34.95% fall in its net profit margins since last 3-months.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.02 - a 300% jump from last quarter’s estimates.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current year stand at 0.02.

Myriad Genetics Inc.’s earning per share (EPS) jumped 300% since last year same period to 0.06 in the Q3 2024. This indicates that the Myriad Genetics Inc. has generated 300% annual rate of jump in its earning per share (EPS) in the last 4 quarters.